Načítá se...
Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data
BACKGROUND/AIM: New treatment regimens for COVID-19, which has threatened the world recently, continue to be investigated. Although some of the treatments are promising, it is thought to be early to state that there is definitive treatment. Experiences and treatment protocol studies from treatment c...
Uloženo v:
| Vydáno v: | Turk J Med Sci |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Scientific and Technological Research Council of Turkey
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7991889/ https://ncbi.nlm.nih.gov/pubmed/32682360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-2005-82 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|